
    
      The tri-functional anti-CD19 chimeric antigen receptor contains an anti-CD19 scFv, a PD-L1
      blocker, and a cytokine complex, enabling the CD19-TriCAR-T to simultaneously targeting the
      CD19 positive NHL cellsï¼Œblocking the inhibitory PD-L1 signal and stimulating T/NK cell
      activation and expansion.
    
  